Early toxicity of hypofractionated radiotherapy for prostate cancer

Early toxicity of hypofractionated radiotherapy for prostate cancer

Background: Hypofractionated accelerated radiotherapy (HART) is now a feasible option for prostate cancer treatment apropos toxicity, biochemical control and shortening of treatment. The aim of this study was to investigate hypofractionated schedules in the treatment of patients with localized prost...

Full description

Bibliographic Details
Main Authors: Pavel Krupa, Hana Ticha, Tomas Kazda, Radana Dymackova, Jana Zitterbartova, Anna Odlozilikova, Libor Kominek, Lukas Bobek, Ales Kudlacek, Pavel Slampa
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2016-09-01
Series:Biomedical Papers
Subjects:
hypofractionationation
vmat
volumetric arc therapy
rapidarc
tumor control probability
normal tissue complication probability
alternated time schedule
Online Access:https://biomed.papers.upol.cz/artkey/bio-201603-0016_Early_toxicity_of_hypofractionated_radiotherapy_for_prostate_cancer.php

Internet

https://biomed.papers.upol.cz/artkey/bio-201603-0016_Early_toxicity_of_hypofractionated_radiotherapy_for_prostate_cancer.php

Similar Items